<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d84">
    <sentence id="DDI-DrugBank.d84.s0" text="The concomitant administration of Exjade and aluminum-containing antacid preparations has not been formally studied.">
        <entity charOffset="34-39" id="DDI-DrugBank.d84.s0.e0" text="Exjade" type="brand"/>
        <entity charOffset="45-52" id="DDI-DrugBank.d84.s0.e1" text="aluminum" type="drug"/>
        <entity charOffset="65-84" id="DDI-DrugBank.d84.s0.e2" text="antacid preparations" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s0.e0" e2="DDI-DrugBank.d84.s0.e1" id="DDI-DrugBank.d84.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s0.e0" e2="DDI-DrugBank.d84.s0.e2" id="DDI-DrugBank.d84.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s0.e1" e2="DDI-DrugBank.d84.s0.e2" id="DDI-DrugBank.d84.s0.p2"/>
    <negationtags>The concomitant administration of Exjade and aluminum-containing antacid preparations has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been formally studied. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s1" text="Although deferasirox has a lower affinity for aluminum than for iron, Exjade should not be taken with aluminum-containing antacid preparations.">
        <entity charOffset="9-19" id="DDI-DrugBank.d84.s1.e0" text="deferasirox" type="drug"/>
        <entity charOffset="46-53" id="DDI-DrugBank.d84.s1.e1" text="aluminum" type="drug"/>
        <entity charOffset="64-67" id="DDI-DrugBank.d84.s1.e2" text="iron" type="drug"/>
        <entity charOffset="70-75" id="DDI-DrugBank.d84.s1.e3" text="Exjade" type="brand"/>
        <entity charOffset="102-109" id="DDI-DrugBank.d84.s1.e4" text="aluminum" type="drug"/>
        <entity charOffset="122-141" id="DDI-DrugBank.d84.s1.e5" text="antacid preparations" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e0" e2="DDI-DrugBank.d84.s1.e1" id="DDI-DrugBank.d84.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e0" e2="DDI-DrugBank.d84.s1.e2" id="DDI-DrugBank.d84.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e0" e2="DDI-DrugBank.d84.s1.e3" id="DDI-DrugBank.d84.s1.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e0" e2="DDI-DrugBank.d84.s1.e4" id="DDI-DrugBank.d84.s1.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e0" e2="DDI-DrugBank.d84.s1.e5" id="DDI-DrugBank.d84.s1.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e1" e2="DDI-DrugBank.d84.s1.e2" id="DDI-DrugBank.d84.s1.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e1" e2="DDI-DrugBank.d84.s1.e3" id="DDI-DrugBank.d84.s1.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e1" e2="DDI-DrugBank.d84.s1.e4" id="DDI-DrugBank.d84.s1.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e1" e2="DDI-DrugBank.d84.s1.e5" id="DDI-DrugBank.d84.s1.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e2" e2="DDI-DrugBank.d84.s1.e3" id="DDI-DrugBank.d84.s1.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e2" e2="DDI-DrugBank.d84.s1.e4" id="DDI-DrugBank.d84.s1.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e2" e2="DDI-DrugBank.d84.s1.e5" id="DDI-DrugBank.d84.s1.p11"/>
        <pair ddi="true" e1="DDI-DrugBank.d84.s1.e3" e2="DDI-DrugBank.d84.s1.e4" id="DDI-DrugBank.d84.s1.p12" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e3" e2="DDI-DrugBank.d84.s1.e5" id="DDI-DrugBank.d84.s1.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s1.e4" e2="DDI-DrugBank.d84.s1.e5" id="DDI-DrugBank.d84.s1.p14"/>
    <negationtags>Although deferasirox has a lower affinity for aluminum than for iron, Exjade should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be taken with aluminum-containing antacid preparations. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s2" text="In healthy volunteers, Exjade had no effect on the pharmacokinetics of digoxin.">
        <entity charOffset="23-28" id="DDI-DrugBank.d84.s2.e0" text="Exjade" type="brand"/>
        <entity charOffset="71-77" id="DDI-DrugBank.d84.s2.e1" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s2.e0" e2="DDI-DrugBank.d84.s2.e1" id="DDI-DrugBank.d84.s2.p0"/>
    <negationtags>In healthy volunteers, Exjade had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on the pharmacokinetics of digoxin. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s3" text="The effect of digoxin on Exjade pharmacokinetics has not been studied.">
        <entity charOffset="14-20" id="DDI-DrugBank.d84.s3.e0" text="digoxin" type="drug"/>
        <entity charOffset="25-30" id="DDI-DrugBank.d84.s3.e1" text="Exjade" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s3.e0" e2="DDI-DrugBank.d84.s3.e1" id="DDI-DrugBank.d84.s3.p0"/>
    <negationtags>The effect of digoxin on Exjade pharmacokinetics has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been studied. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s4" text="The concomitant administration of Exjade and vitamin C has not been formally studied.">
        <entity charOffset="34-39" id="DDI-DrugBank.d84.s4.e0" text="Exjade" type="brand"/>
        <entity charOffset="45-53" id="DDI-DrugBank.d84.s4.e1" text="vitamin C" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s4.e0" e2="DDI-DrugBank.d84.s4.e1" id="DDI-DrugBank.d84.s4.p0"/>
    <negationtags>The concomitant administration of Exjade and vitamin C has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been formally studied. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s5" text="Doses of vitamin C up to 200 mg were allowed in clinical studies without negative consequences.">
        <entity charOffset="9-17" id="DDI-DrugBank.d84.s5.e0" text="vitamin C" type="drug"/>
    <negationtags>Doses of vitamin C up to 200 mg were allowed in clinical studies &lt;scope&gt; &lt;cue&gt; without &lt;/cue&gt; negative consequences. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s6" text="The interaction of Exjade with hydroxyurea has not been formally studied.">
        <entity charOffset="19-24" id="DDI-DrugBank.d84.s6.e0" text="Exjade" type="brand"/>
        <entity charOffset="31-41" id="DDI-DrugBank.d84.s6.e1" text="hydroxyurea" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s6.e0" e2="DDI-DrugBank.d84.s6.e1" id="DDI-DrugBank.d84.s6.p0"/>
    <negationtags>The interaction of Exjade with hydroxyurea has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been formally studied. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s7" text="No inhibition of deferasirox metabolism by hydroxyurea is expected based on the results of an in vitro study.">
        <entity charOffset="17-27" id="DDI-DrugBank.d84.s7.e0" text="deferasirox" type="drug"/>
        <entity charOffset="43-53" id="DDI-DrugBank.d84.s7.e1" text="hydroxyurea" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d84.s7.e0" e2="DDI-DrugBank.d84.s7.e1" id="DDI-DrugBank.d84.s7.p0"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; inhibition of deferasirox metabolism by hydroxyurea is expected based on the results of an in vitro study. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s8" text="Exjade should not be combined with other iron chelator therapies, as safety of such combinations has not been established.">
        <entity charOffset="0-5" id="DDI-DrugBank.d84.s8.e0" text="Exjade" type="brand"/>
    <negationtags>Exjade should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be combined with other iron chelator therapies, as safety of such combinations has not been established. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d84.s9" text="Drug/Food Interactions The bioavailability (AUC) of deferasirox was variably increased when taken with a meal.">
        <entity charOffset="52-62" id="DDI-DrugBank.d84.s9.e0" text="deferasirox" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d84.s10" text="Deferasirox should be taken on an empty stomach 30 minutes before eating.">
        <entity charOffset="0-10" id="DDI-DrugBank.d84.s10.e0" text="Deferasirox" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d84.s11" text="Exjade tablets for oral suspension can be dispersed in water, orange juice, or apple juice.">
        <entity charOffset="0-5" id="DDI-DrugBank.d84.s11.e0" text="Exjade" type="brand"/>
    </sentence>
</document>